1403819-30-6

Basic information

• Product Name: N-(3-((dimethylamino)methyl)phenyl)-5-(2-fluorophenyl)-1H-pyrazolo[4,3-d]pyrimidin-7-amine
• Synonyms: N-(3-((dimethylamino)methyl)phenyl)-5-(2-fluorophenyl)-1H-pyrazolo[4,3-d]pyrimidin-7-amine
• CAS NO: 1403819-30-6
• Molecular Weight: 362.409
• Mol File: 1403819-30-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3-((dimethylamino)methyl)phenyl)-5-(2-fluorophenyl)-1H-pyrazolo[4,3-d]pyrimidin-7-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-((dimethylamino)methyl)phenyl)-5-(2-fluorophenyl)-1H-pyrazolo[4,3-d]pyrimidin-7-amine(1403819-30-6)
• EPA Substance Registry System: N-(3-((dimethylamino)methyl)phenyl)-5-(2-fluorophenyl)-1H-pyrazolo[4,3-d]pyrimidin-7-amine(1403819-30-6)

Safety Data

• Hazardous Substances Data: 1403819-30-6(Hazardous Substances Data)

Upstream product

• 1403819-41-9 7-chloro-5-(2-fluorophenyl)-2-(4-methoxybenzyl)-2H-pyrazolo[4,3-d]pyrimidine 
• 27958-77-6 3-((dimethylamino)methyl)aniline 

Relevant articles and documents

PYRAZOLO [4, 3-D] PYRIMIDINES USEFUL AS KINASE INHIBITORS

The present invention relates to novel compounds of formula (I) that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases. These diseases include autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cancer, cardiovascular diseases, allergies, asthma, alzheimer's disease, parkinson's disease, skin disorders, eye diseases, infectious diseases and hormone-related diseases.